Trainimal (TRML) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
13 Jun, 2025Executive summary
Net sales for Q2 2024/2025 were 2,654 TSEK, nearly flat year-over-year, with operating loss narrowing to -40 TSEK from -115 TSEK.
EBITDA improved to 574 TSEK from 344 TSEK, and cash flow from operations remained positive at 456 TSEK.
The company continues to focus on cost control and product quality, with investments in app development and international expansion.
Financial highlights
Q2 net sales: 2,654 TSEK (2,681 TSEK prior year); H1 net sales: 5,283 TSEK (5,384 TSEK prior year).
Q2 operating result: -40 TSEK (-115 TSEK); Q2 EBITDA: 574 TSEK (344 TSEK).
Q2 result before tax: -41 TSEK (-144 TSEK); EPS: -0.02 SEK (-0.06 SEK).
Cash flow from operations Q2: 456 TSEK (433 TSEK); H1: 907 TSEK (394 TSEK).
Bruttomarginal for subscriptions Q2: 72.7% (60.2%).
Outlook and guidance
English-language app rollout to resume soon, with expanded food database for global reach.
Expansion to focus on the Basic service, which shows high profitability and customer uptake.
Market remains sluggish, with slow recovery in consumer spending expected.
Latest events from Trainimal
- Q2 delivered robust sales growth, higher margins, and new medical partnerships, sustaining momentum.TRML
Q2 25/2619 Dec 2025 - Returned to profit in Q1 with higher margins, lower CAC, and strong cash flow.TRML
Q1 25/2619 Sep 2025 - Q4 saw a return to profitability, record margins, and strong cost discipline, setting up for future growth.TRML
Q4 24/2519 Jun 2025 - Net sales and ARPU fell, but gross margin and recurring revenue stayed robust.TRML
Q1 24/2513 Jun 2025 - EBITDA turned positive and customer numbers hit a record after the new app launch.TRML
Q4 23/2413 Jun 2025 - Gross margin and EBITDA improved despite lower sales, with positive cash flow achieved.TRML
Q3 24/256 Jun 2025